Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,701,000
Closed -$4.22M 3981
2024
Q1
$4.22M Buy
+1,701,000
New +$4.43M 0.01% 1579
2023
Q4
Sell
-5,055,100
Closed -$13M 3941
2023
Q3
$13M Buy
+5,055,100
New +$14.6M 0.03% 663

Other funds holding ABEV

Squarepoint's ABEV Position: Q1 2026 in Review

Squarepoint increased its Ambev (ABEV) stake by 78% in Q1 2026, buying an estimated $659K and bringing the position to 525,785 shares worth $1.54M. The position accounts for ﹤0.01% of the portfolio, ranked #2406.

Squarepoint first reported a position in ABEV in Q4 2016 and has held it in 25 quarters since. The position peaked at $8.66M in Q3 2023. 402 funds tracked by Wall St. Rank hold ABEV as of Q1 2026.

  • Squarepoint held 525,785 shares of Ambev worth $1.54M as of Q1 2026.
  • Squarepoint bought 230,708 Ambev shares in Q1 2026, an estimated $659K.
  • Ambev made up ﹤0.01% of Squarepoint's portfolio in Q1 2026, its #2406 holding.
  • Squarepoint first reported a position in Ambev in Q4 2016 and has held it in 25 quarters since.
  • Squarepoint's Ambev position peaked at $8.66M in Q3 2023.
  • 402 funds tracked by Wall St. Rank held Ambev as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.